Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That would be totally sweet!!
IMO, this could be the last power hour before ARYC enters an entirely different world next week. If they start dropping fins Monday, things change dramatically for the better. If you wish to buy really cheap shares, now's the time. All IMO.
That's why it's important for people to not sell into the bid! Don't give your shares away!!
Somebody that wants to sell shares needs to learn to quit selling into the bid, and go with some smaller orders and sell at the ask so it doesn't slow any mo-mo that develops. Come on people!!!
What a great marketing opportunity to reach a number of allergy practitioners. From the conference website:
Clinical Updates in Allergy and Immunology 2018 is organized by Mayo Clinic and will be held from Jul 27 - 29, 2018 at Hotel del Coronado, Coronado, California, United States of America.
The target audience for this medical event is allergists, internists, family medicine physicians, and pediatricians. It will also benefit nurses, physician assistants, nurse practitioners and others involved in primary care with a specific interest in allergy. This CME Conference has been approved for a maximum of 17.25 AMA PRA Category 1 Credits.
Conference Description :
Clinical Updates in Allergy and Immunology is designed to deliver a present-day understanding of allergic disorders with an emphasis on the translation of allergy knowledge to clinical practice. The focus for this inaugural year is ‘food-related allergic disorders’ which will be presented in addition to many common allergy conditions. This structured theme-based program will include evidence-based and emerging clinical approaches presented by expert faculty from allergy and other medical specialties to provide a comprehensive and multidisciplinary perspective on allergic disorders.
IMO, if Mark is still saying '14/'15 fins will still come out this month, he's got the finished product in hand.
Crazyjerry, no PM here, but I will say if it were me, I would hang in there. No dilution, it may go down some more, but IMO will spring back shortly with a vengeance. I'm just a little younger than you, and have more invested at a higher pps than you, but I'm not selling any shares-if I did, I feel I would regret it shortly. I doubt the professor is selling either. Too many good events could be imminent that keep me from selling right now: Fins coming soon (very possibly by Tuesday), FDA approval, large contracts coming, etc, etc.
Of course there's no guarantee of any of this, but it does look very promising. I try to block out a lot of the noise going on any time a good stock goes down. There's always panic by some, manipulation by others, and a lot of FUD (Fear, Uncertainty and Doubt) negativism. Remember, it went up much further than this and pretty fast. You can expect it to aggressively go down at times also. Although gut wrenching, I just weather the storm when this happens if I have a keeper of a company, which I believe I have with Arrayit.
I heard a little saying once that is so true in times like these. "Don't doubt in darkness what you believe in the light." There's a lot of progress and incredible accomplishment Arrayit has made. Keep going over those things to get the "real" picture. Delsurfer and MikeCr have some good posts yesterday that give an indication of progress that's been made in 4 years. IMO, we're about to see the financial results of that progress.
All I say is my opinion only; you need to do what's best for you. But I'm staying the course. GLTU and all investors here.
I think that tweet we're all waiting for is coming in the next few days, and possibly some other announcements. I noticed in his response to you, he listed all the social media sites. I've never seen that in a response from him..til today. In a response to an email from me today, he said:
Please follow us on Twitter for real-time daily updates and stay tuned for our upcoming press releases. We look forward to your continued participation. Thanks, Mark
arrayit.com/index.html
https://twitter.com/arrayit
https://www.instagram.com/Arrayit_Corporation/
An after hours tweet tomorrow about a Monday release would be a nice treat to mull over for the weekend, that is for those who still have a full complement of shares : )
Well said, Cary. Ditto for me, except not quite as good of gains as you have, but still hefty. Good luck to you and all investors from here going forward. I think these gains we've had to this point will end up being peanuts compared to what we'll gain in the long term. Can't wait to start with fins.
Thanks, Mike. Great stuff. Arrayit has come a long way. That's why many of us longs are holding for what's coming down the road.
Another day at the OTC office : ) The company is no different today than last week. Haven't sold a share and don't plan to for a while. IMO, great things ahead-and shortly.
Coming soon.
Dear Cary, Thanks very much for your support and feedback. Our financial team has provided all requested documents to RRBB and we have regular communication with the auditors. We are still anticipating the first financials to post this month and to be fully current by this summer. We will announce the posting of each audit (2014/2015, 2016, 2017 and 2018 review) the day before via Twitter. We look forward to your continued support and participation. Thanks, Mark
I don't buy it. If Arrayit was waiting on Taub, they would be ultra foolish to be messing with the FDA, buy side brokers, Albertsons, shareholders (including family members, neighbors and close friends who are heavily invested here), etc, etc by not publishing fins when they said they would. I guess we'll have to wait to see...summertime is the right time.
Let the share price games continue. Someday soon, this stock will escape to a new orbit, then we'll see who plays games.
Tweets can come at any time. The company will post fins when ready.
Thanks Sloan. The latest HUGE breadcrumbs:
New Tweet: Arrayit senior management completes analyst call with top buy side analyst at the prestigious Alpha Deal Group headquartered in New York NY USA and providing premium independent due diligence for high net-worth retail, instituional and hedge fund customers (link: http://www.alphadealgroup.com) alphadealgroup.com
Interesting Focus At Alpha Deal Group:
"We cover event-driven, mispriced equity growth opportunities. Each of our select buy-side client equity coverage selections are special long-only situation scenarios in uniquely positioned companies with compelling micro-drivers that are in alignment with our macro outlook."
All the wringing of hands every time there's some retracement or consolidation. Good grief. Follow all the breadcrumbs people, and relax. This will explode upward soon.
Days like today help the RSI to come down to be ready for the next run.
Point well taken Smokenjoe. Mark's response indicates to me that nothing has changed the plan to file '14/'15 by Tuesday. Granted, something could change between now and then I guess. I'm of the opinion (just a gut feeling) that '14/'15 have been complete for a while and the hold up has been with the more recent fins. Guess we'll find out soon enough!
No kidding. Good patience. This is the fun time. Should be enjoyed-like the anticipation of a kid on Christmas eve! No bah-humbug here. Gifts to receive within a week!!
People need to relax. IMO, as per Mark's response to cary, we have a max of 1 week to wait for fins to start dropping. If you need more shares, now's the time. If not, be patient and be ready for ARYC to launch!
Mark just replied:
Dear Cary, Thanks very much for your support and feedback. Our financial team has provided all requested documents to RRBB and we have regular communication with the auditors. We are still anticipating the first financials to post this month and to be fully current by this summer. We will announce the posting of each audit (2014/2015, 2016, 2017 and 2018 review) the day before via Twitter. We look forward to your continued support and participation. Thanks, Mark
I thought Mark's response to directmoney was informative.
Dear Owner, Arrayit can achieve a 4b valuation in two ways: (1) Old Fashioned Way - 80m revs with 40m earnings trading at 100x earnings is 4b and (2) Wall Street Valuation - the market valued Theranos at 9b based on being able to “run hundreds of tests from a few drops of blood", which Arrayit does in its normal course of business. 9b x 55% discount for Theranos being private is 4b. Thanks, Mark
Same to you and all PTC!
Yikes. You’re wrong. ARYC going waaaaaay up soon.
You can bet there will be those who try to spread fear, uncertainty and doubt when '14/'15 fins arrive, in order to capitalize on the moment. I'm not sure it works for maybe more than a few hours, if that, since most holders here are in for the long haul and won't be selling, but may even be buying more.
I've been of the thinking that '14/'15 fins will be published on a Friday since I anticipate they'll be poor. However, the more I think about it, the Monday news cycle may continue with publishing fins since the positive impact of moving to being current may be perceived to be of greater value than the negative impact of poor fins. We'll find out REAL SOON now. Can't wait.
Supposedly '14 and '15 were the worst, with better results as time goes along.
I wonder if there's a PR Monday, what it will be about???
Great news, techmover, thanks for sharing! Now we know that it'll be '14/'15 within the next 10 days or so. Fantastic! Get ready to rumble!!!!!!
You are correct, the smart money looks for the current numbers. Arrayit has much more annual income than $2.8M from just one 1 contract signed in 2016-and there's far more:
9-12-2016: Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.
Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.
— Arrayit Corporation (@arrayit) September 12, 2016
After they become current.
FDA approval means A LOT to many lenders, investors, customers and potential customers, and to possible suitors : )
Expect to see an impressive PR this week in regards to this meeting with the FDA.
Thanks for the positive report, Hugie.
Today’s opinion, the overall signal based on where the price lies in reference to the common interpretation of all 13 studies, for Arrayit Corp (ARYC) is Buy.
Yep. And they've scammed the buy side broker, and the FDA among others. LOL
Great TA Farah. I think next week will be a big one for ARYC.
It looks like ARYC will churn til the next BURN! Congrats to all who have held long, and to newcomers who plan to do the same. IMO, there are great rewards ahead for those who stick with it.
When the next big round of news hits, this is upward bound. Thanks, TravO, and all other longs for the great comments and DD!
Almost 7% increase today. Haven't heard from you all day. Whatsup???
STICK da fork !!!!!!!! Party is over here at 0.1 - That was it
will drop everyday for many days now
Have a good company visit Thursday!